Recombinant multi-species PARK7/DJ-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PARK7/DJ-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The product of this gene belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. Defects in this gene are the cause of autosomal recessive early-onset Parkinson disease 7. Two transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CAP1,DJ-1,DJ1,Dj1,GATD2,HEL-S-67p,Maillard deglycase,Oncogene DJ1,PARK7,Park7,Parkinson disease protein 7,Parkinsonism-associated deglycase,Protein DJ-1 (DJ-1),Protein/nucleic acid deglycase DJ-1,SP22

Target products collectionGo to PARK7/DJ-1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP4114-Ag-1/ GM-Tg-hg-IP4114-Ag-2 Human PARK7/DJ-1 protein Human
GM-Tg-rg-IP4114-Ag-1/ GM-Tg-rg-IP4114-Ag-2 Rat PARK7/DJ-1 protein Rat
GM-Tg-mg-IP4114-Ag-1/ GM-Tg-mg-IP4114-Ag-2 Mouse PARK7/DJ-1 protein Mouse
GM-Tg-cynog-IP4114-Ag-1/ GM-Tg-cynog-IP4114-Ag-2 Cynomolgus/Rhesus macaque PARK7/DJ-1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP4114-Ag-1/ GM-Tg-felg-IP4114-Ag-2 Feline PARK7/DJ-1 protein Feline
GM-Tg-cang-IP4114-Ag-1/ GM-Tg-cang-IP4114-Ag-2 Canine PARK7/DJ-1 protein Canine
GM-Tg-bovg-IP4114-Ag-1/ GM-Tg-bovg-IP4114-Ag-2 Bovine PARK7/DJ-1 protein Bovine
GM-Tg-equg-IP4114-Ag-1/ GM-Tg-equg-IP4114-Ag-2 Equine PARK7/DJ-1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP4114-Ag-1/ GM-Tg-hg-IP4114-Ag-2; GM-Tg-rg-IP4114-Ag-1/ GM-Tg-rg-IP4114-Ag-2;
GM-Tg-mg-IP4114-Ag-1/ GM-Tg-mg-IP4114-Ag-2; GM-Tg-cynog-IP4114-Ag-1/ GM-Tg-cynog-IP4114-Ag-2;
GM-Tg-felg-IP4114-Ag-1/ GM-Tg-felg-IP4114-Ag-2; GM-Tg-cang-IP4114-Ag-1/ GM-Tg-cang-IP4114-Ag-2;
GM-Tg-bovg-IP4114-Ag-1/ GM-Tg-bovg-IP4114-Ag-2; GM-Tg-equg-IP4114-Ag-1/ GM-Tg-equg-IP4114-Ag-2
Products Name PARK7/DJ-1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PARK7/DJ-1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PARK7/DJ-1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.